A Multi-center, Randomized Parallel Group, Placebo-Controlled Double-Blind Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standard Therapy in Pediatric Patients with Systemic Lupus Er
Read time: 1 mins
Last updated:18th Apr 2012
� Evaluate the safety and tolerability of belimumab in the pediatric SLE population � Evaluate the pharmacokinetics of belimumab in the pediatric SLE population. � Evaluate the efficacy of belimumab in the pediatric SLE population � Evaluate the effects of belimumab on the quality of life in the pediatric SLE population.
|Study start date||2012-04-18|